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Release of Henrietta Lacks' genome causes uproar
It was only one genome, among the many thousand that have now been sequenced and released publicly. But this wasn't just any sequence; it was the sequence of Henrietta Lacks, a tobacco farmer whose ovarian cancer cells, HeLa, have launched countless research projects. A news release from the European Molecular Biology Laboratory, where the genome was recently sequenced, was greeted mostly with yawns by the media until some realized that the lab had neither sought nor received permission from Lacks' descendants to release the data. A flurry of activity on social media alerted Rebecca Skloot, author of the best-selling book The Immortal Life of Henrietta Lacks, who investigated the situation through discussions with researchers and the family. Her opinion piece in the New York Times on 23 March 2013 outlined the ethical, legal, and social issues that arise from this case and foreshadow a legal quagmire to come unless our privacy policies and legal protections are updated in parallel with our technology-and in a hurry. 
Planning for individualized cancer screening programs see pages 423 and 437
We justify public health screening for cancer by estimating that the benefits of public surveillance outweigh the attendant risks, which include false-positive test results and its associated psychological stress. Public acceptance of and participation in screening programs relies on trust and perceived benefit. Genomically informed screening aims to provide an individualized risk profile that incorporates genomic risk and demographic features to influence how and when each person should be screened. In this issue, Chowdhury et al. examine the ramifications of population-based genomic risk stratification. The authors present the recommendations from a series of workshops convened in 2010 and 2011 by the Foundation for Genomics and Population Health and the University of Cambridge. Genomic information, they explain, could help triage individuals into new risk categories that include genetic risk when determining the appropriate level of cancer screening, including the possibility of earlier screening for those at highest risk and less frequent screening for those at lowest risk. The authors suggest that more personalized communication of risk information may help increase the use of existing screening methods. However, they stress that acquiring and using personal genetic information as part of a population-based screening program will inevitably result in concerns about discrimination and stigmatization.
In an accompanying Special Article, Khoury et al. suggest that our current knowledge of genetic risk for common diseases is insufficient to justify screening in most cases. In the case of colorectal cancer screening, however, they suggest that awareness of genetic risk factors may provide better risk information than family history alone. They also stress that it is unclear whether genetic risk stratification will help distinguish life-threatening cancers from milder manifestations, an ongoing concern with current screening programs. 
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